Correlation Engine 2.0
Clear Search sequence regions


  • adult (1)
  • bisoprolol (1)
  • case report (1)
  • chest discomfort (1)
  • digoxin (1)
  • heart (1)
  • heart rate (1)
  • humans (1)
  • man (1)
  • normal sinus rhythm (1)
  • patient (7)
  • pyridines (2)
  • sleep (1)
  • tablets (1)
  • valsartan (1)
  • zolpidem (12)
  • Sizes of these terms reflect their relevance to your search.

    Zolpidem is a non-benzodiazepine hypnotic widely used to manage insomnia. Zolpidem-triggered atrial fibrillation (AF) in patients with cardiomyopathy has never been reported before. A 40-year-old man with Duchenne muscular dystrophy-related cardiomyopathy attempted suicide and developed new-onset AF after zolpidem overdose. One year before admission, the patient visited our clinic due to chest discomfort and fatigue after daily walks for 1 month; both electrocardiography (ECG) and 24-hour Holter ECG results did not detect AF. After administration of cardiac medication (digoxin 0.125 mg/day, spironolactone 40 mg/day, furosemide 20 mg/day, bisoprolol 5 mg/day, sacubitril/valsartan 12/13 mg/day), he felt better. AF had never been observed before this admission via continuous monitoring during follow-up. Sixteen days before admission, the patient saw a sleep specialist and started zolpidem tartrate tablets (10 mg/day) due to insomnia for 6 months; ECG results revealed no significant change. The night before admission, the patient attempted suicide by overdosing on 40 mg of zolpidem after an argument, which resulted in severe lethargy. Upon admission, his ECG revealed new-onset AF, necessitating immediate cessation of zolpidem. Nine hours into admission, AF spontaneously terminated into normal sinus rhythm. Results from the ECG on the following days and the 24-hour Holter ECG at 1-month follow-up showed that AF was not detected. This study provides valuable clinical evidence indicating that zolpidem overdose may induce AF in patients with cardiomyopathy. It serves as a critical warning for clinicians when prescribing zolpidem, particularly for patients with existing heart conditions. Further large-scale studies are needed to validate this finding and to explore the mechanisms between zolpidem and AF. © 2024. The Author(s).

    Citation

    Xiaolin Li, Yunpeng Jin. Zolpidem-triggered atrial fibrillation in a patient with cardiomyopathy: a case report. BMC cardiovascular disorders. 2024 Jul 04;24(1):339

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 38965461

    View Full Text